Literature DB >> 8447934

The mechanisms of action of cyclosporin A in the treatment of psoriasis.

R L Wong1, C M Winslow, K D Cooper.   

Abstract

This article describes the effects of cyclosporin A (CsA) on the immunopathological mechanisms operative in psoriasis, a human skin disease. The main focus is the effect of CsA on keratinocytes, T cells and antigen-presenting cells, the key players in lesional psoriatic skin. The effect of CsA on other cells, such as neutrophils and endothelial cells, which are important in the maintenance of psoriasis, are also discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8447934     DOI: 10.1016/0167-5699(93)90061-o

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  11 in total

1.  Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation.

Authors:  Hideaki Sugiyama; Rolland Gyulai; Eiko Toichi; Edina Garaczi; Shinji Shimada; Seth R Stevens; Thomas S McCormick; Kevin D Cooper
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422

Review 2.  Contact dermatitis. Clinical perspectives and basic mechanisms.

Authors:  A Nasir; A A Gaspari
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

3.  Amphiregulin and epidermal hyperplasia: amphiregulin is required to maintain the psoriatic phenotype of human skin grafts on severe combined immunodeficient mice.

Authors:  Narasimharao Bhagavathula; Kamalakar C Nerusu; Gary J Fisher; Gao Liu; Archana B Thakur; Lorraine Gemmell; Shankar Kumar; Zenghai H Xu; Paul Hinton; Naoya Tsurushita; Nicholas F Landolfi; John J Voorhees; James Varani
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

4.  CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes.

Authors:  J C Chang; L R Smith; K J Froning; B J Schwabe; J A Laxer; L L Caralli; H H Kurland; M A Karasek; D I Wilkinson; D J Carlo
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

5.  Is an epitope on keratin 17 a major target for autoreactive T lymphocytes in psoriasis?

Authors:  A S Gudmundsdottir; H Sigmundsdottir; B Sigurgeirsson; M F Good; H Valdimarsson; I Jonsdottir
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

Review 6.  Recognition and treatment of psoriasis. Special considerations in elderly patients.

Authors:  C Bonifati; M Carducci; A Mussi; L D'Auria; F Ameglio
Journal:  Drugs Aging       Date:  1998-03       Impact factor: 3.923

7.  Interleukin-8 is a cyclosporin A binding protein.

Authors:  H Bang; K Brune; C Nager; U Feige
Journal:  Experientia       Date:  1993-07-05

Review 8.  Ustekinumab: a new option in psoriasis therapy.

Authors:  Anna L Chien; James T Elder; Charles N Ellis
Journal:  Drugs       Date:  2009-06-18       Impact factor: 9.546

9.  Effect of cyclosporin A on inflammatory cytokine production by U937 monocyte-like cells.

Authors:  J E Garcia; M R de Cabo; F M Rodríguez; J P Losada; A J López; J L Arellano
Journal:  Mediators Inflamm       Date:  2000       Impact factor: 4.711

10.  Production and Selectivity of Key Fusarubins from Fusarium solani due to Media Composition.

Authors:  Sebastian Birkedal Kristensen; Tobias Bruun Pedersen; Mikkel Rank Nielsen; Reinhard Wimmer; Jens Muff; Jens Laurids Sørensen
Journal:  Toxins (Basel)       Date:  2021-05-25       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.